Novel protein may identify more aggressive prostate cancersBMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7160.701a (Published 12 September 1998) Cite this as: BMJ 1998;317:701
- Scott Gottlieb
- New York
The level of p27 protein in patients with prostate cancer may identify those who have a more aggressive form of the disease with a higher rate of recurrence and poorer long term survival. Such patients may benefit from aggressive treatment, whereas others could be saved from unnecessary treatment.
Many researchers agree that the p27 protein has an important role in controlling the growth of at least four different cancers arising in the body's epithelial tissue. In the latest study researchers found that the protein was abundant in tissue taken from normal prostate glands and …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial